Tuesday, May 28, 2024
Home Tags Positive

Tag: positive

‘Positive results from PK study with cobitolimod’ selected as one of...

0
STOCKHOLM, Aug. 22, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the positive results from the pharmacokinetic (PK) study with...

Bio-Thera Solutions Announces Positive Phase 1 Clinical Data for BAT8006 (Folate…...

0
GUANGZHOU, China, Aug. 12, 2023 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative assets and biosimilars,...

Bio-Thera Solutions Announces Positive Phase 1 Clinical Data for BAT8006 (Folate…...

0
GUANGZHOU, China, Aug. 12, 2023 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative assets and biosimilars,...

Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus...

0
Chikungunya vaccine candidate met all the co-primary endpoints of the Phase 3 study and was shown to be highly immunogenic in the majority...

Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Pha… – Press...

0
Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating proof-of-mechanism for ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibodyRapid, dose-related,...

Positive Results Announced from Phase 3 OCARINA II Trial Evaluating Roche’s...

0
SAN DIEGO, July 13, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. HALO ("Halozyme") today announced that Roche's Phase 3 OCARINA II trial evaluating OCREVUS®...

89bio Publishes Positive Results from Phase 2 ENTRIGUE Trial of Pegozafermin...

0
– Published data showed consistent and significant reductions in triglycerides, atherogenic lipoproteins and liver fat, and pegozafermin's favorable safety and tolerability profile ––...

New ENRICH-PLUS Study Builds on World’s First Positive Clinical Trial for...

0
NICO awards University of Maryland $200,000 for first-of-its-kind study combining MIPS with neuroprotectant for basal ganglia ICHINDIANAPOLIS, June 22, 2023 /PRNewswire/ -- Just two...

Annovis Bio Receives Excellent Safety Rating and Positive Recommendation to Cont…...

0
The drug is proving to be safe and well-tolerated Annovis Bio, Inc. ANVS, announces the positive safety review by the Data and Safety Monitoring...

Intellia Therapeutics Announces New Positive Clinical Data from Phase 1 Study...

0
Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Across all patients...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News